Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,138,995
Closed -$33.5M 81
2021
Q4
$33.5M Sell
1,138,995
-125,814
-10% -$4.74M 0.74% 36
2021
Q3
$43.6M Sell
1,264,809
-1,292,784
-51% -$44.2M 0.98% 30
2021
Q2
$80.8M Sell
2,557,593
-206,829
-7% -$6.66M 1.65% 20
2021
Q1
$86.2M Buy
2,764,422
+612,715
+28% +$18.4M 1.7% 20
2020
Q4
$64.8M Sell
2,151,707
-95,492
-4% -$2.82M 1.22% 25
2020
Q3
$57.3M Buy
2,247,199
+583,597
+35% +$15.5M 1.07% 31
2020
Q2
$43.1M Sell
1,663,602
-225,997
-12% -$6M 0.78% 35
2020
Q1
$49.6M Sell
1,889,599
-1,129,065
-37% -$35.5M 0.79% 34
2019
Q4
$98.2M Buy
+3,018,664
New +$97.7M 1.05% 24

Other funds holding EXC

Sarah Ketterer's EXC Position: Q1 2022 in Review

Sarah Ketterer sold out of Exelon (EXC) in Q1 2022, closing a stake of 1,138,995 shares — an estimated $33.5M sold.

Sarah Ketterer first reported a position in EXC in Q4 2019 and held it in 9 quarters. The position peaked at $98.2M in Q4 2019. 1,026 funds tracked by Wall St. Rank hold EXC as of Q1 2022.

  • Sarah Ketterer reported no remaining Exelon position as of Q1 2022 after selling out during the quarter.
  • Sarah Ketterer sold 1,138,995 Exelon shares in Q1 2022, an estimated $33.5M.
  • Sarah Ketterer first reported a position in Exelon in Q4 2019 and held it in 9 quarters.
  • Sarah Ketterer's Exelon position peaked at $98.2M in Q4 2019.
  • 1,026 funds tracked by Wall St. Rank held Exelon as of Q1 2022.

Based on Causeway Capital Management's 13F filing for Q1 2022, filed 13 May 2022.